|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 401/06 | (2006.01) |
| A61K 31/4439 | (2006.01) | ||
| A61P 31/18 | (2006.01) |
| (11) | Number of the document | 2552902 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11761856.1 |
| Date of filing the European patent application | 2011-03-28 | |
| (97) | Date of publication of the European application | 2013-02-06 |
| (45) | Date of publication and mention of the grant of the patent | 2015-03-11 |
| (46) | Date of publication of the claims translation | 2015-07-27 |
| (86) | Number | PCT/CA2011/000320 |
| Date | 2011-03-28 |
| (87) | Number | WO 2011/120133 |
| Date | 2011-10-06 |
| (30) | Number | Date | Country code |
| 321573 P | 2010-04-07 | US | |
| 318824 P | 2010-03-30 | US |
| (72) |
BURCH, Jason, US
COTE, Bernard, CA
NGUYEN, Natalie, CA
LI, Chun, Sing, CA
ST-ONGE, Miguel, CA
GAUVREAU, Danny, CA
|
| (73) |
Merck Canada Inc.,
16711 Trans-Canada Highway, Kirkland QC H9H 3L1,
CA
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Nenukleozidinės reversinės transkriptazės inhibitoriai |
| NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS |
| Payment date | Validity (years) | Amount | |
| 2026-02-09 | 16 | 347.00 EUR |
| 2027-03-28 |